Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.

scientific article published on June 1996

Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID8803908

P2093author name stringFox RI
Dixon R
Krubel S
Guarrasi V
P921main subjectSjögren's syndromeQ335555
hydroxychloroquineQ421094
P304page(s)S31-6
P577publication date1996-06-01
P1433published inLupusQ6704846
P1476titleTreatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study
P478volume5 Suppl 1

Reverse relations

cites work (P2860)
Q35176597A review on recent advances in dry eye: Pathogenesis and management
Q37156391Antibodies against carbamylated proteins are present in primary Sjögren's syndrome and are associated with disease severity
Q36880610Bone Mineral Density in Sjögren Syndrome Patients with and Without Distal Renal Tubular Acidosis
Q36844843Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis
Q41943683Chloroquine-induced bull's eye maculopathy in rheumatoid arthritis: related to disease duration?
Q35555698Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome
Q36989837Effect of Hydroxychloroquine Treatment on Dry Eyes in Subjects with Primary Sjögren's Syndrome: a Double-Blind Randomized Control Study
Q41936291Hydroxychloroquine improves dry eye symptoms of patients with primary Sjogren's syndrome
Q37827403Hydroxychloroquine: from malaria to autoimmunity
Q33667694Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis
Q35556009Lamivudine is not effective in primary Sjögren's syndrome
Q36131422Low-intensity pulsed ultrasound rescues insufficient salivary secretion in autoimmune sialadenitis
Q64094947Managing fatigue in patients with primary Sjögren's syndrome: challenges and solutions
Q38840388New Treatment Guidelines for Sjögren's Disease
Q48341665Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
Q35555323Primary Sjögren's syndrome: new clinical and therapeutic concepts
Q52234497Rational drug therapy recommendations for the treatment of patients with Sjögren's syndrome.
Q90052759Recent advances in the search for a targeted immunomodulatory therapy for primary Sjögren's syndrome
Q30234992Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment
Q26777907Salivary Secretory Disorders, Inducing Drugs, and Clinical Management
Q33777026Sialendoscopic management of autoimmune sialadenitis: a review of literature.
Q39019614Sjögren Syndrome and Other Causes of Sicca in Older Adults
Q87353703Sjögren syndrome
Q37053804Sjögren's syndrome: diagnosis and therapeutic challenges in the elderly
Q38561490Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases
Q44498935Topical and systemic medications for the treatment of primary Sjögren's syndrome.
Q33695804Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome
Q30249011Treatment of primary Sjögren syndrome
Q90003803Update on Sjögren Syndrome and Other Causes of Sicca in Older Adults
Q79145258[Sjögren's syndrome. Current aspects from a rheumatological point of view]
Q87328501[Sjögren's syndrome]

Search more.